¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"reversible ischemic neurologic deficit"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
¿µ¹® transient ischemic attack(TIA) ÇÑ±Û Àϰú¼ºÇãÇ÷¹ßÀÛ
¼³¸í   
  ³úÇ÷°ü Æó¼â¿¡ ÀÇÇÑ Àϰú¼ºÀÇ ½Ç½Å, µÎÅë, ½Ã·Â»ó½Ç µîÀÇ Áõ¼¼¸¦ º¸À̴ »óÅ·Π24½Ã°£ À̳»¿¡ ¸ðµç Áõ»óÀ̠ȸº¹µÇ´Â °æ¿ì¸¦ ¸»ÇÑ´Ù. ÈÄ¿¡ ¿µ±¸ÀûÀΠ³úÇãÇ÷ Áï ³ú°æ»öÁõÀÌ ¿Ã °¡´É¼ºÀÌ ¸Å¿ì ³ô¾ÆÁø´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • delayed ischemic neurological deficit
    Áö¿¬ÇãÇ÷½Å°æÇÐÀû°á¼Õ
  • neurologic
    ½Å°æÇÐÀû-
  • neurologic examination
    ½Å°æÇÐÀû°Ë»ç
  • reversible change
    °¡¿ªº¯È­
  • reversible colloid
    °¡¿ªÄÝ·ÎÀ̵å
  • reversible cycle
    °¡¿ªÈ¸·Î
  • reversible hydrocolloid
    °¡¿ª¼ö¼ºÄÝ·ÎÀ̵å
  • reversible inhibition
    °¡¿ª¾ïÁ¦
  • reversible obstructive lung disease
    °¡¿ªÆó¼âÆóº´, °¡¿ªÆó¼âÆóÁúȯ
  • reversible polymerization
    µÇÁý±âÁßÇÕ, °¡¿ªÁßÇÕ
  • reversible reaction
    °¡¿ª¹ÝÀÀ
  • attention deficit
    ÁÖÀǷ°áÇÌ
  • attention deficit disorder
    ÁÖÀǷ°áÇÌÀå¾Ö
  • attention deficit hyperactivity disorder
    ÁÖÀǷ°áÇ̰ú´ÙȰµ¿Àå¾Ö
  • base deficit
    ¿°±â°áÇÌ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 10 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • neurologic examination
    ½Å°æÇа˻ç
  • reversible reaction
    °¡¿ª¹ÝÀÀ
  • deficit
    ºÎÁ·, °áÇÌ
  • attention deficit
    ÁÖÀǷ°áÇÌ
  • attention-deficit hyperactivity disorder
    ÁÖÀǷ°áÇ̰ú´ÙȰµ¿Àå¾Ö
  • transient ischemic attack
    Àϰú¼ºÇãÇ÷¹ßÀÛ
  • ischemic
    ÇãÇ÷-
  • ischemic injury
    ÇãÇ÷¼Õ»ó
  • acute ischemic brachial neuropathy
    ±Þ¼ºÇãÇ÷À§ÆÈ½Å°æº´Áõ
  • ischemic optic neuropathy
    ÇãÇ÷½Ã°¢½Å°æº´Áõ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • delayed ischemic neurological deficit
    Áö¿¬ÇãÇ÷½Å°æ°áÇÔ
  • neurologic examination
    ½Å°æÇÐÀû°Ë»ç
  • neurologic
    ½Å°æÇÐÀû-
  • attention deficit
    ÁÖÀǷ°áÇÌ
  • deficit
    ºÎÁ·, °áÇÌ
  • deficit syndrome
    °áÇÌÁõÈıº
  • proton flow deficit
    ¾çÀÚÈ帧°áÇÌ
  • pulse deficit
    ¸Æ¹Ú°á¼Õ
  • saturation deficit
    Æ÷È­ºÎÁ·µµ, Æ÷È­ºÎÁ··®
  • reversible change
    °¡¿ªº¯È­
  • reversible colloid
    °¡¿ªÄÝ·ÎÀ̵å
  • reversible cycle
    °¡¿ªÈ¸·Î
  • reversible obstructive lung disease
    °¡¿ªÆó¼âÆóº´
  • reversible electrode
    °¡¿ªÀü±Ø
  • reversible heat
    µÇÁý±â¿­, ¿­°¡¿ª¼º
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 11 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • RIMA, see reversible inhibitor of MAO-A
    °¡¿ªÀû ´Ü°¡¾Æ¹Î-A »êÈ­È¿¼Ò¾ïÁ¦Á¦
  • heat reversible
    ¿­°¡¿ª¼º(æðʦæ½àõ)ÀÇ.
  • heat reversible
    ¿­°¡¿ª¼º(Ëç˧ËçËÛ)ÀÇ.
  • pulse deficit
    ¸Æ¹Ú°á¼Õ.
  • pulse deficit
    ¸Æ¹Ú°á¼Õ(ØæÚÑÌÀáß)
  • pulsus deficit
    ¸Æ¹Ú°á¼Õ.
  • TIA=£¾transient ischemic attack
    Àϰú¼º ÇãÇ÷¹ßÀÛ, Àϰú¼º ºóÇ÷¹ßÀÛ.
  • anterior ischemic optic neuropathy
    Àü¹æÇãÇ÷¼º ½Ã½Å°æº´Áõ(îñÛ°úÈúìàõãÊãêÌèÜ»ñø).
  • anterior ischemic optic neuropathy
    ¾ÕÇãÇ÷½Ã½Å°æº´Áõ
  • hypertensive ischemic ulcer
    °íÇ÷¾Ð¼º Ç÷ °áÇ̼º ±Ë¾ç
  • posterior ischemic optic neuropathy
    ÈÄÇãÇ÷½Ã½Å°æº´Áõ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • neurologic assessment
  • neurologic disorder
    ½Å°æÁúȯ
  • neurologic examination
    ½Å°æÇÐÀû °Ë»ç.
  • neurologic examination
    ½Å°æÇÐÀû°Ë»ç
  • oral neurologic disturbances
    ±¸°­½Å°æÀå¾Ö(¡­ãêÌèî¡äô).
  • attention deficit hyperactivity disorder
    ÁÖÀǷ°áÇÌ °ú´ÙȰµ¿Àå¾Ö(º´)
  • attention deficit with hyperactivity
    °ú´ÙȰµ¿µ¿¹Ý ÁÖÀǷ°áÇÌ
  • attention-deficit disorder(ADD)
    ÁÖÀǷ°áÇÌÀå¾Ö(º´)
  • base deficit
    ¿°±â°áÇÌ, ¿°±âºÎÁ·(ç¤ÐñÝÕ ðë).
  • base excess/deficit
    ¿°±â°úÀ×/°áÇÌ
  • deficit oxygen
    »ê¼Ò°áÇÌ(Ë×ËÛ˭̰).
  • deficit syndrome
    °áÇÌÁõÈıº(ÌÀù¹ñøý¦ÏØ)
  • denial- of- deficit syndrome
    °áÇÌ ºÎÁ¤ ÁõÈıº(ÌÀù¹ÜúïÒñøý¦ÏØ)
  • negative symptom =deficit s.
    Å»¶ôÁõ»ó, ¹«Áõ»ó.
  • oxygen deficit
    »ê¼Ò°áÇÌ.
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Ischemic phase
    ÇãÇ÷±â
    [¿¾ ¿ë¾î] ºóÇ÷±â
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 7 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • primary alkali deficit
    ¿ø¹ß¼º(ê«Û¡àõ) ¾ËÄ®¸®°áÇÌ(ÌÀù¹)
  • primary carbon dioxide deficit
    ¿ø¹ß¼º ÀÌ»êȭź¼Ò °áÇÌ(ê«Û¡àõì£ß«ûù÷©áÈÌÀù¹)
  • reversible boundary spreading test
    °¡¿ª °æ°è ºÐ»ê ½ÃÇè(ʦæ½ÌÑÍ£ÝÂߤãËúÐ)
  • reversible inhibitor
    °¡¿ª ÀúÇØÁ¦(îÁúªð¥)
  • reversible metabolic pathway
    °¡¿ª ´ë»ç°æ·Î(ÓÛÞóÌèÖØ)
  • reversible process
    °¡¿ª °úÁ¤(Φïï)
  • reversible reaction
    °¡¿ª ¹ÝÀÀ(Úãëë)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 9 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • neurologic examination
    ½Å°æÇÐÀû°Ë»ç
  • deficit
    ºÎÁ·, °á¼Õ, °áÇÌ
  • proton flow deficit
    ¾çÀÚÀ¯µ¿°áÇÌ
  • reversible
    °¡¿ª¼ºÀÇ
  • reversible change
    °¡¿ªº¯È­
  • ischemic
    ÇãÇ÷¼ºÀÇ
  • ischemic colitis
    ÇãÇ÷¼º´ëÀå¿°
  • ischemic heart disease
    ÇãÇ÷¼º ½ÉÁúȯ
  • ischemic necrosis
    ÇãÇ÷¼º±«»ç
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
RIND Residual(= Reversible) Ischemic Neurologic Deficit
PRIND prolonged reversible ischemic neurologic deficit
RIND reversible ischemic neurologic deficit
ND Doctor of Naturopathy; nasal deformity; natural death; Naval Dispensary; neonatal death; neoplastic ...
ECG Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ
   = EKG
  1. Conducting System Structu...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
RIND reversible ischemic neurologic deficit
RIND REVERSIBLE ISCHEMIC NEUROLOGICAL DEFICIT
RIA Reversible Ischemic Attacks
DIND Delayed ischemic neurological deficit
RPLS Reversible posterior leucoencephalopathy syndrome
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • reversible ischemic neurologic deficit
    °¡¿ªÀû ÇãÇ÷¼º ½Å°æ °á¼Õ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • deficit syndrome
    °áÇÌ ÁõÈıº
  • denial-of-deficit syndrome
    °áÇÌ ºÎÁ¤ ÁõÈıº
  • neurological deficit
    ½Å°æ¼º °á¼Õ
  • proton flow deficit
    ¾çÀÚ À¯µ¿ °áÇÌ
  • salt deficit dehydration
    ¿°·ù °áÇ̼º Å»¼öÁõ
  • sensory deficit
    °¨°¢ °áÇÌ
  • CNS ischemic response
    ÁßÃß ½Å°æ ÇãÇ÷ ¹ÝÀÀ
  • ischemic area
    ÇãÇ÷ ºÎÀ§
  • ischemic CVA
    ÇãÇ÷¼º ³úÁ¹Áß
    1
  • ischemic heart disease
    ÇãÇ÷¼º ½É Áúȯ
  • ischemic oculopathy
    ÇãÇ÷ ¾Èº´Áõ
  • ischemic paralysis
    ÇãÇ÷¼º ¸¶ºñ
    Àü»öÁõÀ̳ª Ç÷ÀüÁõ¿¡¼­¿Í °°ÀÌ ¼øÈ¯ÀÇ °¨¼Ò¿¡ ÀÇÇÑ ±¹¼ÒÀû ¸¶ºñ.
  • posterior ischemic optic neuropathy
    ÈÄÇãÇ÷ ½Ã½Å°æº´Áõ
  • heat reversible
    ¿­ °¡¿ª¼ºÀÇ
    ¿­À» °¡ÇÏ¸é ¿ø·¡ÀÇ »óÅ·Πµ¹¾Æ¿À´Â.
  • naloxone reversible
    ³¯·Ï¼Õ °¡¿ª¼º
    naloxoneÀ¸·Î ÇØµ¶ ¶Ç´Â ´ëÄ¡ ÇÒ ¼ö ÀÖ´Â.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
mice, neurologic mutants Mice which carry mutant genes for neurologic defects or abnormalities.
(12 Dec 1998)
neurologic <anatomy> Pertaining to neurology or to the nervous system.
(18 Nov 1997)
neurologic manifestations Neurologic disorders attendant upon non-neurologic disease or injury.
(12 Dec 1998)
neurologic symptom Neurologic symptoms can be variable.
Examples include: numbness, tingling, hyperesthesia (increased sensitivity), paralysis, localised weakness, dysarthria (difficult speech), aphasia (inability to speak), dysphagia (difficulty swallowing), diplopia (double vision), amaurosis fugax (temporary loss of vision in one eye) difficulty walking, incoordination, tremor, seizures, confusion, lethargy, dementia, delirium and coma. All the above can be symptoms of stroke.
(27 Sep 1997)
attention deficit disorder An inability to control behaviour due to difficulty in processing neural stimuli.
(12 Dec 1998)
attention deficit disorder with hyperactivity A behaviour disorder originating in childhood in which the essential features are signs of developmentally inappropriate inattention, impulsivity, and hyperactivity. Although most individuals have symptoms of both inattention and hyperactivity-impulsivity, one or the other pattern may be predominant. The disorder is more frequent in males than females. Onset is in childhood. Symptoms often attenuate during late adolescence although a minority experience the full complement of symptoms into mid-adulthood.
(12 Dec 1998)
attention deficit hyperactivity disorder <psychiatry> A condition seen in children where there is increased motor activity in association with poor attention span. Often treated with amphetamine medications.
(27 Sep 1997)
base deficit A decrease in the total concentration of blood buffer base, indicative of metabolic acidosis or compensated respiratory alkalosis.
(05 Mar 2000)
pulse deficit The absence of palpable pulse waves in a peripheral artery for one or more heart beats, as is often seen in atrial fibrillation, the number of such missing pulse waves (usually expressed as heart rate minus pulse rate per minute).
(05 Mar 2000)
deficit A lack or deficiency.
(18 Nov 1997)
oxygen deficit The difference between oxygen uptake of the body during early stages of exercise and during a similar duration in a steady state of exercise; sometimes considered as the formation of the oxygen debt.
(05 Mar 2000)
reversible Capable of going through a series of changes in either direction, forward or backward, as a reversible chemical reaction.
(18 Nov 1997)
reversible calcinosis A form of calcinosis sometimes observed in patients who constantly ingest large quantities of milk and alkaline medicines, as in the treatment of peptic ulcer.
(05 Mar 2000)
reversible colloid A colloid that is again soluble in water after having been dried at ordinary temperature.
Synonym: stable colloid.
(05 Mar 2000)
reversible decortication A temporary loss of function of the cerebral cortex.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • reversible
    °Å²Ù·Î ÇÒ ¼ö ÀÖ´Â
  • reversible
    ¿ªÀ¸·Î(°Å²Ù·Î)ÇÒ ¼ö ÀÖ´Â;(ÀǺ¹µî)¾ÈÆÆÀ¸·Î ÀÔÀ» ¼ö ÀÖ´Â;¾ÈÆÆÀÌ ¾ø°Ô § õ;¾ÈÆÆÀ¸·Î ÀÔÀ»¼ö ÀÖ´Â ¿Ê;reversibility
  • deficit
    °á¼Õ; ÀûÀÚ
  • deficit
    °á¼Õ;ºÎÁ·¾×
  • deficit financing
    (Á¤ºÎÀÇ)ÀûÀÚ ÀçÁ¤(Á¤Ã¥)
  • deficit spending
    ÀûÀÚ ÁöÃâ
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á